ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
NurExone Biologic Inc

NurExone Biologic Inc (J90)

0.38
-0.018
(-4.52%)
Closed January 28 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.38
Bid
0.356
Ask
0.404
Volume
100,609
0.37 Day's Range 0.42
0.191 52 Week Range 0.92
Previous Close
0.398
Open
0.384
Last Trade
250
@
0.39
Last Trade Time
Average Volume (3m)
73,925
Financial Volume
-
VWAP
-

J90 Latest News

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“NurExone” or the “Company”), a developer of exosome-based...

NurExone Biologic Secures Master Cell Bank

TORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a developer of exosome-based...

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

TORONTO and HAIFA, Israel, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study

TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce compelling...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.042-9.952606635070.4220.4480.37400220.40095497DE
4-0.062-14.02714932130.4420.4840.37339950.42707945DE
12-0.082-17.74891774890.4620.57999990.37739250.48665229DE
26-0.042-9.952606635070.4220.57999990.324562940.4551541DE
520.18291.91919191920.1980.920.1911153180.51900265DE
1560.23153.3333333330.150.920.151058490.51746532DE
2600.23153.3333333330.150.920.151058490.51746532DE

J90 - Frequently Asked Questions (FAQ)

What is the current NurExone Biologic share price?
The current share price of NurExone Biologic is 0.38 €
What is the 1 year trading range for NurExone Biologic share price?
NurExone Biologic has traded in the range of 0.191 € to 0.92 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
H9WHwa Ag
3.62 €
(63.06%)
105.19k
0PV2Moovly Media Inc
0.007 €
(55.56%)
650
IFGAAtari SA
0.1695 €
(36.69%)
1.32M
41KQuebec Rare Earth Elements Corp
0.0435 €
(29.85%)
1.02k
76M0Realbotix Corp
0.322 €
(29.84%)
613.19k
5MCLeap Therapeutics Inc
0.635 €
(-70.33%)
12.4k
WWTWater Ways Technologies Inc
0.002 €
(-60.00%)
180k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-40.00%)
17k
LL3PanGenomic Health Inc
0.1401 €
(-36.23%)
161
OU5AAvalon Advanced Materials Inc
0.0142 €
(-34.86%)
206.52k
D7GNel ASA
0.2018 €
(7.91%)
7.94M
NVDNVIDIA Corp
123.24 €
(9.06%)
2.48M
3MWLivium Ltd
0.0088 €
(-12.00%)
2.17M
3CPXiaomi Corporation
4.88 €
(6.45%)
2.15M
IFGAAtari SA
0.1695 €
(36.69%)
1.32M

Discussion

View Full Feed
BeachBum BeachBum 39 seconds ago
Put them all up for .0001 and see what happens. You could have sold yesterday or today. Pay attention.
PSRU
JustJack JustJack 54 seconds ago
POS dilution CEO dilutes another 200 million shares because the RadCam is not selling or the Rosa or any crappy device. 

13,708,594,118

Worst CEO ever! 
AITX
dig4gold dig4gold 2 minutes ago
I’m starting to wonder
CGAC
bb8675309 bb8675309 2 minutes ago
Shorting stocks should be illegal.
AVXL
Almosthere Almosthere 2 minutes ago
Finally a voice of reason on this board. Thank you!
LQMT
Bring The Heat Bring The Heat 3 minutes ago
He gets paid to respond so of course he will take the bait
HMBL
BullNBear52 BullNBear52 3 minutes ago
I noticed that myself but choose to ignore it.
BullNBear52 BullNBear52 5 minutes ago
Perhaps. But who will want to learn about art history unless they have been exposed to it.

I have the Louvre on my agenda this summer and still have hopes of visiting the Hermitage.
zab zab 6 minutes ago
Kind of sensitive,  aren't you, poor soul.
jealmc79 jealmc79 6 minutes ago
They report shell ratios of around 20%. There is some additional loss of fiber in the reeling process. Those were the basis of my estimates.
A cocoon shell is made of more than just fiber. It also contains 25-30% sericin by weight. So your numbers aren't anywhere close to being accurate.
KBLB
Jp_SHMP Jp_SHMP 6 minutes ago
another nice one



George Myers
@GeorgeMyers1081
·
2h
Replying to
@LongBullyStick
$IGPK $JFHE Thank you for translating and posting!
This quote is quite important: "We will use the Zhixin Life platform as a carrier, INTEG
IGPK JFHE
Jackxkr Jackxkr 8 minutes ago
Weird you see no hiring as positive. No hiring can mean they won't need employees as well as they don't have any work
NWBO
xoom xoom 8 minutes ago
This prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
COOP
BigBadWolf BigBadWolf 9 minutes ago
191 copy & paste n
RDAR
mineanddine mineanddine 9 minutes ago
Fake business story, fake financials, laughable website.  Scam.  
HIRU
crazy horse 0 crazy horse 0 10 minutes ago
"The wind propels refrigerant gas-filled condoms attached to incendiary devices into Israeli territory after being released by a group of masked Palestinians near the Israel-Gaza border."

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/475279334_1295414811510175_7898629216333812036
roadkilll roadkilll 11 minutes ago
How many patients on the generic fit the skinny label indication (less than 100?)
Icosapent ethyl capsules are indicated: as an adjunct to diet to reduce TG levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. Prescribed with no expectation of reducing CV risk benefit.
AMRN
vlispxpert vlispxpert 11 minutes ago
surprised screen not kicking out anything new...guess the dip wasn't big enough! lol
vuletini vuletini 12 minutes ago
Beta male
SHIBUSD
3331 3331 12 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
Zorax Zorax 13 minutes ago
Well, I would say the possible habit of rubbing ones eyes when tired or getting up is out of the question.
Sos28493 Sos28493 13 minutes ago
Your target price to sell millions?
VPLM

Your Recent History

Delayed Upgrade Clock